Scotland revises Drug Tariff regarding specials and unlicensed medicines
August 26 2015
Scottish Drug Tariff changes affecting the authorisation process for the supply of specials and imported unlicensed medicines will come into effect on September 1.
An NHS Circular has been issued setting out the changes which apply to Part 7 of the Drug Tariff. Arrangements have been revised for specials for which a reimbursement price is not listed in Part 7S of the Drug Tariff. In addition, the list of items in Part 7S has been extended. The measures are being introduced to help streamline the approval process, says the circular.
For items listed in Part 7S, pharmacy contractors will require no prior authorisation from their Health Board before ordering and dispensing the item, and the contractor will be reimbursed the amount listed there. Any further reimbursement will be paid only in exceptional cases - for example where the item is required next day and out of pocket (OOP) expenses may arise, but the contractor will require prior Health Board authorisation to claim above the tariff price.
For items not listed in Part 7S but available as a commercially made up item, contractors should follow the ‘Generic Framework for Specials Authorisation Process across Scotland’ which is included in the Circular and has also been posted on the Community Pharmacy Scotland website.
The Generic Framework says that no health board authorisation is required for products not listed in Part 7S where:
- authorisation has been obtained for a patient prescription within last 12 months with less than 20% price variation from original authorisation
- the preparation is available from an NHS manufacturing unit within Scotland, England or Wales
- the prescription is endorsed with the fixed non part 7S handling charge as a handling charge (hc)
- if other OOP expenses apply (including wholesaler handling charges) these should be endorsed as postage and packing costs (pp)
Health board authorisation is otherwise required where the product is not in Part 7S. In addition:
- contractors should source one quote which includes postage and packing, handling charges, shelf life etc.
- reauthorisation is required for the same patient and product if price varies by more than 20% from the original authorisation prescription
- for items prescribed long term, reauthorisation is required after 12 months for clinical validation
- prescription endorsements should be done electronically and on paper with the invoice price, less any rebate plus any additional cost authorised such as OOP expenses (including wholesaler handling charge) should be endorsed as postage and packing costs (pp)
- the prescription should be endorsed with the fixed non Part 7S handling charge of £30 as a handling charge (hc)
The Circular also contains details about record keeping requirements and CPS has created a key facts sheet summarising the information.